Update on in vitro susceptibility testing of Streptococcus pneumoniae;Puesta al día en el estudio de susceptibilidad de Streptococcus pneumoniae

Revista Chilena de Infectologia

Volumn 19, Issue SUPPL. 2, 2002, Pages

  Palavecino R , Elizabeth ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Break points; Streptococcus pneumoniae; Susceptibility testing

Indexed keywords

EID: 27744485096     PISSN: 07161018     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (6)

1. PALAVECINO E L. The crisis of the resistant pathogens in respiratory tract infections-Use of pharmacodynamic principles. Am J Managed Care 2001; 7: S170-S177.
2. JACOBS M R, BAJAKSOUZIAN S, ZILLES A, LIN G, PANKUCH G, APPELBAUM P C. Susceptibilities de Streptococcus pneumoniae and Haemophilus influenzae to 10 oral antimicrobial agents based on pharmacodynamic parameters: 1997 U.S. surveillance study. Antimicrob Agents Chemother 1999; 43: 1901-8.
3. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. Twelve informational supplement M100-S12. Wayne, Pennsylvania: NCCLS, 2002.
4. PALAVECINO E L, RIEDEL I, BERRIOS X et al. Prevalence and mechanisms of macrolide resistance in Streptococcus pyogenes in Santiago, Chile. Antimicrob Agents Chemother 2001; 45: 339-41.
5. FASOLA E L. BAJAKSOUZIAN S, APPELBAUM P C, JACOBS M R. Variation in erythromycin and clindamycin susceptibility testing of Streptococcus pneumoniae with four test methods. Antimicrob Agent Chemother 1997; 41: 129-34.
6. NAGAI K, DAVIES T, EDNIE L et al. Activities of a new fluoroketolide HMR 3787 and its (des)-fluor-derivative RU 64339 compared to telithromycin, erythromycin, azithromycin, clarithro-mycin and clindamycin against a variety of macrolide susceptible and resistant Streptococcus pyogenes. Antimicrob Agents Chemother 2001; 45: 3242-5.